Your browser doesn't support javascript.
loading
Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition.
Oh, Jaewon; Lee, Beom Seob; Lim, Gibbeum; Lim, Heejung; Lee, Chan Joo; Park, Sungha; Lee, Sang-Hak; Chung, Ji Hyung; Kang, Seok-Min.
Afiliación
  • Oh J; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee BS; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascular Diseases (SIRIC), Yonsei University Health System, Seoul, Republic of Korea.
  • Lim G; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascu
  • Lim H; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascu
  • Lee CJ; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Park S; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascu
  • Lee SH; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascu
  • Chung JH; Department of Applied Bioscience, College of Life Science, CHA University, Gyeonggi-do, Republic of Korea.
  • Kang SM; Cardiology, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Graduate Program in Science for Aging, Yonsei University, Seoul, Republic of Korea; Severance Integrative Research Institute for Cerebral and Cardiovascu
J Mol Cell Cardiol ; 138: 244-255, 2020 01.
Article en En | MEDLINE | ID: mdl-31866378
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiotónicos / Doxorrubicina / Citoprotección / Miocitos Cardíacos / Atorvastatina / Proteína Forkhead Box O1 / Survivin Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Mol Cell Cardiol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cardiotónicos / Doxorrubicina / Citoprotección / Miocitos Cardíacos / Atorvastatina / Proteína Forkhead Box O1 / Survivin Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Mol Cell Cardiol Año: 2020 Tipo del documento: Article